• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对鲍曼不动杆菌的体外抗生素协同作用的荟萃分析。

A meta-analysis of in vitro antibiotic synergy against Acinetobacter baumannii.

作者信息

March Gabriel A, Bratos Miguel A

机构信息

Service of Microbiology and Immunology, University Clinic Hospital of Valladolid, Ramón y Cajal Avenue n°3, 47003, Valladolid, Spain.

Service of Microbiology and Immunology, University Clinic Hospital of Valladolid, Ramón y Cajal Avenue n°3, 47003, Valladolid, Spain; Department of Microbiology, Faculty of Medicine, University of Valladolid, Av. Ramón y Cajal n°7, 47005, Valladolid, Spain.

出版信息

J Microbiol Methods. 2015 Dec;119:31-6. doi: 10.1016/j.mimet.2015.09.014. Epub 2015 Sep 28.

DOI:10.1016/j.mimet.2015.09.014
PMID:26415528
Abstract

The aim of the work was to describe the different in vitro models for testing synergism of antibiotics and gather the results of antibiotic synergy against multidrug-resistant Acinetobacter baumannii (MDR-Ab). The different original articles were obtained from different web sites. In order to compare the results obtained by the different methods for synergy testing, the Pearson chi-square and the Fischer tests were used. Moreover, non-parametric chi-square test was used in order to compare the frequency distribution in each analysed manuscript. In the current meta-analysis 24 manuscripts, which encompassed 2016 tests of in vitro synergism of different antimicrobials against MDR-Ab, were revised. Checkerboard synergy testing was used in 11 studies, which encompasses 1086 tests (53.9%); time-kill assays were applied in 12 studies, which encompass 359 tests (17.8%); gradient diffusion methods were used in seven studies, encompassing 293 tests (14.5%). And, finally, time-kill plus checkerboard were applied in two studies, encompassing 278 tests (13.8%). By comparing these data, checkerboard and time-kill methods were significantly more used than gradient diffusion methods (p<0.005). Regarding synergy rates obtained on the basis of the applied method, checkerboard provided 227 tests (20.9%) with a synergistic effect; time-kill assays yielded 222 tests (61.8%) with a synergistic effect; gradient diffusion methods only provided 29 tests (9.9%) with a synergistic effect; and, finally, time-kill plus checkerboard yielded just 15 tests (5.4%) with a synergistic effect. When comparing these percentages, synergy rates reported by time-kill methods were significantly higher than that obtained by checkerboard and gradient diffusion methods (p<0.005). On the basis of the revised data, the combinations of a bactericidal antibiotic plus Tigecycline, Vancomycin or Teicoplanin are not recommended. The best combinations of antibiotics are those which include bactericidal antibiotics such as Carbapenems, Fosfomycin, Amikacin, Polymyxins, Rifampicin and Ampicillin/Sulbactam.

摘要

这项工作的目的是描述用于测试抗生素协同作用的不同体外模型,并收集针对多重耐药鲍曼不动杆菌(MDR-Ab)的抗生素协同作用结果。不同的原始文章来自不同的网站。为了比较不同协同作用测试方法所获得的结果,使用了Pearson卡方检验和Fischer检验。此外,为了比较每篇分析稿件中的频率分布,使用了非参数卡方检验。在当前的荟萃分析中,对24篇稿件进行了修订,这些稿件涵盖了2016次不同抗菌药物对MDR-Ab的体外协同作用测试。11项研究使用了棋盘法协同作用测试,共1086次测试(53.9%);12项研究应用了时间杀菌试验,共359次测试(17.8%);7项研究使用了梯度扩散法,共293次测试(14.5%)。最后,两项研究应用了时间杀菌加棋盘法,共278次测试(13.8%)。通过比较这些数据,棋盘法和时间杀菌法的使用频率明显高于梯度扩散法(p<0.005)。关于基于所应用方法获得的协同率,棋盘法有227次测试(20.9%)具有协同效应;时间杀菌试验有222次测试(61.8%)具有协同效应;梯度扩散法仅有29次测试(9.9%)具有协同效应;最后,时间杀菌加棋盘法仅有15次测试(5.4%)具有协同效应。比较这些百分比时,时间杀菌法报告的协同率明显高于棋盘法和梯度扩散法(p<0.005)。根据修订后的数据,不推荐使用杀菌性抗生素加替加环素、万古霉素或替考拉宁的组合。最佳的抗生素组合是那些包括杀菌性抗生素的组合,如碳青霉烯类、磷霉素、阿米卡星、多粘菌素、利福平和氨苄西林/舒巴坦。

相似文献

1
A meta-analysis of in vitro antibiotic synergy against Acinetobacter baumannii.针对鲍曼不动杆菌的体外抗生素协同作用的荟萃分析。
J Microbiol Methods. 2015 Dec;119:31-6. doi: 10.1016/j.mimet.2015.09.014. Epub 2015 Sep 28.
2
[Do different interpretative methods used for evaluation of checkerboard synergy test affect the results?].[用于评估棋盘协同试验的不同解释方法会影响结果吗?]
Mikrobiyol Bul. 2012 Jul;46(3):410-20.
3
In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.黏菌素、替加环素和多尼培南抗生素组合对广泛耐药和多重耐药鲍曼不动杆菌的体外相互作用
Ann Lab Med. 2016 Mar;36(2):124-30. doi: 10.3343/alm.2016.36.2.124.
4
In vitro activity of doripenem in combination with various antimicrobials against multidrug-resistant Acinetobacter baumannii: possible options for the treatment of complicated infection.多利培南联合各种抗菌药物对多重耐药鲍曼不动杆菌的体外活性:治疗复杂性感染的可能选择。
Microb Drug Resist. 2013 Oct;19(5):407-14. doi: 10.1089/mdr.2012.0250. Epub 2013 May 9.
5
In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.非传统抗菌药物单独或联合使用对从重症监护病房分离出的多重耐药铜绿假单胞菌和鲍曼不动杆菌菌株的体外活性。
Int J Antimicrob Agents. 2006 Mar;27(3):224-8. doi: 10.1016/j.ijantimicag.2005.10.012. Epub 2006 Feb 7.
6
Non-polymyxin-based combinations as potential alternatives in treatment against carbapenem-resistant Acinetobacter baumannii infections.非多黏菌素类联合用药作为治疗碳青霉烯类耐药鲍曼不动杆菌感染的潜在替代品。
Int J Antimicrob Agents. 2020 Oct;56(4):106115. doi: 10.1016/j.ijantimicag.2020.106115. Epub 2020 Jul 25.
7
In vitro effects of tigecycline in combination with colistin (polymyxin E) and sulbactam against multidrug-resistant Acinetobacter baumannii.替加环素联合多黏菌素 E 和舒巴坦对多重耐药鲍曼不动杆菌的体外作用。
J Antibiot (Tokyo). 2013 Dec;66(12):705-8. doi: 10.1038/ja.2013.84. Epub 2013 Aug 28.
8
In Vitro Synergistic Activity of Antimicrobial Agents in Combination against Clinical Isolates of Colistin-Resistant Acinetobacter baumannii.抗菌药物联合对耐黏菌素鲍曼不动杆菌临床分离株的体外协同活性
Antimicrob Agents Chemother. 2016 Oct 21;60(11):6774-6779. doi: 10.1128/AAC.00839-16. Print 2016 Nov.
9
Annual trends in antibiotic resistance of nosocomial Acinetobacter baumannii strains and the effect of synergistic antibiotic combinations.医院鲍曼不动杆菌菌株抗生素耐药性的年度趋势及联合抗生素协同作用的效果
New Microbiol. 2004 Jan;27(1):21-8.
10
In vitro activity of tigecycline in combination with cefoperazone-sulbactam against multidrug-resistant Acinetobacter baumannii.替加环素联合头孢哌酮-舒巴坦对多重耐药鲍曼不动杆菌的体外活性
J Chemother. 2015 Oct;27(5):271-6. doi: 10.1179/1973947814Y.0000000203. Epub 2014 Jul 28.

引用本文的文献

1
activity of sulbactam in combination with other antimicrobial agents against extensively drug-resistant .舒巴坦与其他抗菌药物联合使用对广泛耐药菌的活性。
Microbiol Spectr. 2025 Sep 2;13(9):e0137925. doi: 10.1128/spectrum.01379-25. Epub 2025 Aug 12.
2
Antibiofilm effect of biogenic silver nanoparticle alone and combined with polymyxin B against carbapenem-resistant Acinetobacter baumannii.生物合成银纳米颗粒单独及联合多黏菌素 B 对碳青霉烯类耐药鲍曼不动杆菌的抗生物膜效应。
Braz J Microbiol. 2024 Sep;55(3):2789-2796. doi: 10.1007/s42770-024-01438-3. Epub 2024 Jul 18.
3
Assessing the Potential of Gallic Acid and Methyl Gallate to Enhance the Efficacy of β-Lactam Antibiotics against Methicillin-Resistant by Targeting β-Lactamase: In Silico and In Vitro Studies.
通过靶向β-内酰胺酶评估没食子酸和没食子酸甲酯增强β-内酰胺类抗生素对耐甲氧西林菌疗效的潜力:计算机模拟和体外研究
Antibiotics (Basel). 2023 Nov 13;12(11):1622. doi: 10.3390/antibiotics12111622.
4
The effectiveness of colistin/levofloxacin compared to colistin/meropenem in the treatment of ventilator-associated pneumonia (VAP) caused by carbapenem-resistant : a randomized controlled clinical trial.与黏菌素/美罗培南相比,黏菌素/左氧氟沙星治疗耐碳青霉烯类引起的呼吸机相关性肺炎(VAP)的有效性:一项随机对照临床试验。
Res Pharm Sci. 2022 Dec 24;18(1):39-48. doi: 10.4103/1735-5362.363594. eCollection 2023 Feb.
5
In Vitro Synergistic Activity of Antimicrobial Combinations against Carbapenem- and Colistin-Resistant and .抗菌组合对碳青霉烯类和黏菌素耐药菌的体外协同活性及…… (原文最后不完整)
Antibiotics (Basel). 2023 Jan 5;12(1):93. doi: 10.3390/antibiotics12010093.
6
In vitro synergistic antimicrobial activity of a combination of meropenem, colistin, tigecycline, rifampin, and ceftolozane/tazobactam against carbapenem-resistant Acinetobacter baumannii.美罗培南、黏菌素、替加环素、利福平、头孢他啶/他唑巴坦联合对碳青霉烯类耐药鲍曼不动杆菌的体外协同抗菌活性。
Sci Rep. 2022 May 9;12(1):7541. doi: 10.1038/s41598-022-11464-6.
7
Antimicrobial Synergy Testing: Comparing the Tobramycin and Ceftazidime Gradient Diffusion Methodology Used in Assessing Synergy in Cystic Fibrosis-Derived Multidrug-Resistant .抗菌药物协同试验:比较用于评估囊性纤维化来源的多重耐药菌中协同作用的妥布霉素和头孢他啶梯度扩散法
Antibiotics (Basel). 2021 Aug 12;10(8):967. doi: 10.3390/antibiotics10080967.
8
In Vitro Activities of Colistin and Sitafloxacin Combinations against Multidrug-, Carbapenem-, and Colistin-Resistant Using the Broth Microdilution Checkerboard and Time-Kill Methods.采用肉汤微量稀释棋盘法和时间杀菌法检测多粘菌素与西他沙星联合用药对多重耐药、碳青霉烯耐药和多粘菌素耐药菌的体外活性。
Antibiotics (Basel). 2020 Aug 14;9(8):516. doi: 10.3390/antibiotics9080516.
9
Using machine learning to optimize antibiotic combinations: dosing strategies for meropenem and polymyxin B against carbapenem-resistant Acinetobacter baumannii.利用机器学习优化抗生素组合:美罗培南和多粘菌素B对耐碳青霉烯鲍曼不动杆菌的给药策略
Clin Microbiol Infect. 2020 Sep;26(9):1207-1213. doi: 10.1016/j.cmi.2020.02.004. Epub 2020 Feb 12.
10
Antimicrobial Susceptibility among Colistin, Sulbactam, and Fosfomycin and a Synergism Study of Colistin in Combination with Sulbactam or Fosfomycin against Clinical Isolates of Carbapenem-Resistant .多粘菌素、舒巴坦和磷霉素的药敏性以及多粘菌素与舒巴坦或磷霉素联合对耐碳青霉烯临床分离株的协同作用研究
J Pathog. 2018 Jan 18;2018:3893492. doi: 10.1155/2018/3893492. eCollection 2018.